Search research articles
Contact Us
Filters
Showing results (371-380 of 382) with videos related to
Page
of 39
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
CRISPR-mediated transcriptional activation as a mutation-independent therapeutic strategy for <i>SYNGAP1</i>-related intellectual disability
Laura Sichlinger, Molly B Reilly, Sakshi Arora, et al.
Systematic Biology
|
April 19, 2023
Species Delimitation, Phylogenomics, and Biogeography of Sulawesi Flying Lizards: A Diversification History Complicated by Ancient Hybridization, Cryptic Species, and Arrested Speciation
Jimmy A Mcguire, Xiaoting Huang, Sean B Reilly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 2024
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models
Sonia Jain, Jessica I Griffith, Kendra A Porath, et al.
Proceedings. Biological Sciences
|
June 5, 2019
Habitat preference modulates trans-oceanic dispersal in a terrestrial vertebrate
Mozes P K Blom, Nicholas J Matzke, Jason G Bragg, et al.
Cancer
|
March 14, 2018
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor
Glenwood D Goss, Everett E Vokes, Michael S Gordon, et al.
Molecular Cancer Therapeutics
|
February 28, 2018
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate
Andrew C Phillips, Erwin R Boghaert, Kedar S Vaidya, et al.
Neuro-Oncology Advances
|
February 23, 2023
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma
Benedito A Carneiro, Kyriakos P Papadopoulos, John H Strickler, et al.
Neuro-Oncology Advances
|
September 8, 2022
Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts
Kendra A Porath, Michael S Regan, Jessica I Griffith, et al.
Nature Communications
|
January 7, 2026
Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations
Robert K Suter, Anna M Jermakowicz, Rithvik Veeramachaneni, et al.
The Lancet. Respiratory Medicine
|
March 24, 2023
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial
Elaine Mac Hale, Garrett Greene, Christopher Mulvey, et al.
Page
of 39
Search research articles
Search
Showing results (371-380 of 382) with videos related to
Sort By:
Page
of 39
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
CRISPR-mediated transcriptional activation as a mutation-independent therapeutic strategy for <i>SYNGAP1</i>-related intellectual disability
Laura Sichlinger, Molly B Reilly, Sakshi Arora, et al.
Systematic Biology
|
April 19, 2023
Species Delimitation, Phylogenomics, and Biogeography of Sulawesi Flying Lizards: A Diversification History Complicated by Ancient Hybridization, Cryptic Species, and Arrested Speciation
Jimmy A Mcguire, Xiaoting Huang, Sean B Reilly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 2024
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models
Sonia Jain, Jessica I Griffith, Kendra A Porath, et al.
Proceedings. Biological Sciences
|
June 5, 2019
Habitat preference modulates trans-oceanic dispersal in a terrestrial vertebrate
Mozes P K Blom, Nicholas J Matzke, Jason G Bragg, et al.
Cancer
|
March 14, 2018
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor
Glenwood D Goss, Everett E Vokes, Michael S Gordon, et al.
Molecular Cancer Therapeutics
|
February 28, 2018
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate
Andrew C Phillips, Erwin R Boghaert, Kedar S Vaidya, et al.
Neuro-Oncology Advances
|
February 23, 2023
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma
Benedito A Carneiro, Kyriakos P Papadopoulos, John H Strickler, et al.
Neuro-Oncology Advances
|
September 8, 2022
Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts
Kendra A Porath, Michael S Regan, Jessica I Griffith, et al.
Nature Communications
|
January 7, 2026
Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations
Robert K Suter, Anna M Jermakowicz, Rithvik Veeramachaneni, et al.
The Lancet. Respiratory Medicine
|
March 24, 2023
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial
Elaine Mac Hale, Garrett Greene, Christopher Mulvey, et al.
Page
of 39